FMC Corp vs InMode Ltd — how do they compare? FMC Corp trades at $8.35 (market cap $1.39B), while InMode Ltd trades at $14.21 (market cap $809.93M). The key difference: FMC Corp is the larger of the two by market cap, and FMC Corp pays a 3.59% dividend while InMode Ltd pays none. Which is the better fit depends on your goals — on Pluang, investors hold FMC Corp for 68 Days and InMode Ltd for 28 Days on average.
| FMC | INMD | |
|---|---|---|
Market Cap | $1.39B | $809.93M |
Volume | 4,145,979 | 365,490 |
Sector | Basic Materials | Health |
52-Week High | $30.63 | $16.62 |
52-Week Low | $8.35 | $12.76 |
Typical Hold Time | 68 Days | 28 Days |
Enterprise Value | $5.19B | $313.27M |
Dividend Yield | 3.59% | — |
Signals from Pluang's Aura AI — not financial advice
FMC trades at $8.92, down 1.87% today, reflecting bearish technical signals and weak profitability. The stock shows negative net income margins and ROE, though recent quarterly EPS beat estimates. Cash flow trends are volatile, with 2025 showing negative operational cash flow but positive net cash flow from financing. Analyst consensus is mixed with a near-even split between Buy and Hold ratings, and a price target of $14.60 suggests potential upside. Recent news includes regulatory filings in Brazil and a minority equity investment.
Outlook: FMC faces significant headwinds from declining revenue and negative profitability, but aggressive deleveraging efforts and new product filings offer recovery potential. Risks include high debt, cyclical industry pressures, and execution challenges. The stock may appeal to value investors given low P/S and P/B ratios, but sustained earnings improvement is critical for long-term upside.
INMD trades at $14.08, up 0.5% with mixed technical signals showing bearish moving averages but neutral oscillators. The company maintains strong fundamentals with a P/E of 11.63, gross margins of 76.52%, and consistent revenue around $370M. Recent news includes product innovation with Morpheus8 Cool launch and an unsolicited acquisition offer from Steel Partners at $16.75 per share in July 2026.
Outlook remains cautious with analyst consensus divided (45% Buy, 55% Hold) amid cyclical softness. Investment opportunity lies in potential acquisition premium and international growth, while risks include US sales decline and management capital allocation concerns. The stock faces near-term resistance at $14 with support at the same level.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
FMC is a pure-play crop chemical company. The company has diversified its sales to create a balanced crop chemical portfolio across geographies and crop exposure. Through acquisitions, FMC is now one of the five largest patented crop chemical companies and will continue to develop new products, with a focus on biologicals, through its research and development pipeline.
Read more on FMC →InMode provides innovative medical technologies for minimally invasive surgical procedures. Its platforms use radiofrequency (RF) energy for aesthetic treatments like body contouring and skin tightening.
Read more on INMD →